[Neuropharmacology of apomorphine (review of the literature)].
D000109:Acetylcholine / Q000378:metabolism; D000374:Aggression / Q000187:drug effects; D000437:Alcoholism / Q000188:drug therapy; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology* / Q000627:therapeutic use; D001921:Brain / Q000378:metabolism; D065098:Catechol O-Methyltransferase Inhibitors; D003342:Corpus Striatum / Q000187:drug effects; D004298:Dopamine / Q000378:metabolism; D006168:Guinea Pigs; D006801:Humans; D051379:Mice; D009420:Nervous System / Q000187:drug effects*; D009638:Norepinephrine / Q000378:metabolism; D010300:Parkinson Disease / Q000188:drug therapy; D011817:Rabbits; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects; D012701:Serotonin / Q000378:metabolism; D013239:Stereotyped Behavior / Q000187:drug effects
D065098:Catechol O-Methyltransferase Inhibitors; D011954:Receptors, Dopamine; D012701:Serotonin; D001058:Apomorphine; D000109:Acetylcholine; D004298:Dopamine; D009638:Norepinephrine
Neĭrofarmakologiia apomorfina (obzor literatury).